Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measles; Mumps; Rubella”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Post-approval studies (Phase 4)Study completedNCT03780179
What this trial is testing

MMR at 6 Months Trial

Who this might be right for
Meales-mumps-rubella Vaccine
Rigshospitalet, Denmark 6,540
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Large-scale testing (Phase 3)Study completedNCT00626327
What this trial is testing

Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,630
Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Large-scale testing (Phase 3)UnknownNCT03853785
What this trial is testing

Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

Who this might be right for
Condylomata Acuminata
Assiut University 45
Post-approval studies (Phase 4)Study completedNCT00313950
What this trial is testing

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
Sanofi Pasteur, a Sanofi Company 470
Large-scale testing (Phase 3)Looking for participantsNCT07406360
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Who this might be right for
MeaslesMeasles-Mumps-Rubella+Chickenpox Vaccine
GlaxoSmithKline 1,209
Testing effectiveness (Phase 2)Study completedNCT00578175
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 1,851
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Post-approval studies (Phase 4)Study completedNCT00731965
What this trial is testing

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile Rheumatoid
N.M. Wulffraat 140
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00422292
What this trial is testing

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,664
Post-approval studies (Phase 4)UnknownNCT05952505
What this trial is testing

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Who this might be right for
SARS-CoV-2 InfectionVaricellaMeasles+2 more
Shanghai Municipal Center for Disease Control and Prevention 540
Large-scale testing (Phase 3)Study completedNCT00432523
What this trial is testing

Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)

Who this might be right for
MeaslesMumpsVaricella
Merck Sharp & Dohme LLC 752
Very early researchStudy completedNCT02687763
What this trial is testing

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Who this might be right for
RENAL INSUFFICIENCY, CHRONICLIVER FAILURE, ACUTEHEART DISEASE
Medical University of South Carolina 5
Post-approval studies (Phase 4)Study completedNCT03368495
What this trial is testing

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Who this might be right for
Vaccine Response Impaired
Alba Maria Ropero 851
Testing effectiveness (Phase 2)Study completedNCT00892775
What this trial is testing

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 501
Post-approval studies (Phase 4)Study completedNCT00388440
What this trial is testing

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT04111432
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 372
Next Page